Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 1.68x as of 2026-10-06T20:32:30.333Z.
Calculation as of: 2026-10-06T20:32:30.333Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4ee4545eb4fe5103374f291c717036760539f0ddea1c9b76c24efb1a2679ece0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
1.68x
SECTOR MEDIAN · HEALTHCARE
1.58x
median of 780 covered companies
CURRENT VS SECTOR MEDIAN
+6.67%
vs the sector median at left
Odyssey Therapeutics, Inc.
Market Cap
$870.81M
EV/Assets Ratio
1.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$857.16M
EV/Assets Ratio
0.67x
TTM Avg
0.71x
3Y Avg
0.74x
5Y Avg
0.94x
Market Cap
$884.97M
EV/Assets Ratio
3.17x
TTM Avg
6.41x
3Y Avg
4.83x
5Y Avg
3.58x
Market Cap
$887.99M
EV/Assets Ratio
3.64x
TTM Avg
9.68x
3Y Avg
5.76x
5Y Avg
3.70x
Market Cap
$853.13M
EV/Assets Ratio
1.60x
TTM Avg
2.07x
3Y Avg
2.15x
5Y Avg
2.13x
Market Cap
$852.35M
EV/Assets Ratio
302.19x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Odyssey Therapeutics, Inc. (ODTX) | $870.81M | 1.68x | N/A | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | 3.38x | 2.94x | 2.91x | 3.27x |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | 0.67x | 0.71x | 0.74x | 0.94x |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | 3.17x | 6.41x | 4.83x | 3.58x |
| Alumis Inc. (ALMS)vs › | $855.38M | 1.48x | 3.92x | 2.29x | 2.29x |
| Bioventus Inc. (BVS)vs › | $887.50M | 1.67x | 1.37x | 1.17x | 0.98x |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 3.64x | 9.68x | 5.76x | 3.70x |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 1.60x | 2.07x | 2.15x | 2.13x |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | 302.19x | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | 1.97x | 1.47x | 1.19x | 1.39x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
